Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The SWITCH Trial: A Randomized Controlled Study of Apixaban Versus Vitamin K Antagonists in Patients With HeartMate 3 Left Ventricular Assist Devices

NCT07471139 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.

NCT NCT07471139
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07471139 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The SWITCH Trial: A Randomized Controlled Study of Apixaban Versus Vitamin K Antagonists in Patients With HeartMate 3 Left Ventricular Assist Devices
Lead sponsor
Columbia University
Phase
Phase 3
Overall status
Not yet recruiting
Start date
August 31, 2026
Completion date
August 31, 2029
Enrollment
460 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

bleeding, heart failure, heart transplant, lvad (left ventricular assist device) thrombosis, stroke, thrombosis; artery